Alyeska Investment Group, L.P. historic quarter change: Foreign Stocks, New
In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 23 quarters from 2012-09-30 to 2026-06-30, Alyeska Investment Group, L.P. opened 71 positions, added to 45, reduced 44 and sold out of 63.
- Q2 2026: Stock ENRD; Country of operation —; Class SPON ADS; Shares before 0.
- Q2 2026: Stock NICE; Country of operation —; Class SPONSORED ADR; Shares before 0.
- Q2 2026: Stock TSM; Country of operation —; Class SPONSORED ADS; Shares before 0.
- Q2 2026: Stock IVA; Country of operation —; Class ADS; Shares before 0.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1453072), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-13); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-17); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2008-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30); 2012-09-30 to 2013-06-30 (missing 2012-12-31, 2013-03-31).
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q2 2026 | ENRD
EINRIDE AB | | SPON ADS | 0 | 9,499,352 | +9,499,352 | $0 | $82,169,395 | +$82,169,395 | 2026-08-14 |
|---|
| Q2 2026 | NICE
NICE LTD | | SPONSORED ADR | 0 | 421,949 | +421,949 | $0 | $38,334,067 | +$38,334,067 | 2026-08-14 |
|---|
| Q2 2026 | TSM
TAIWAN SEMICONDUCTOR MANUFAC | | SPONSORED ADS | 0 | 8,422 | +8,422 | $0 | $4,022,095 | +$4,022,095 | 2026-08-14 |
|---|
| Q2 2026 | IVA
INVENTIVA SA | | ADS | 0 | 909,000 | +909,000 | $0 | $3,436,020 | +$3,436,020 | 2026-08-14 |
|---|
| Q2 2026 | SIMO
SILICON MOTION TECHNOLOGY CO | | SPONSORED ADR | 0 | 10,155 | +10,155 | $0 | $3,384,966 | +$3,384,966 | 2026-08-14 |
|---|
| Q2 2026 | ABVX
ABIVAX SA | | SPONSORED ADS | 0 | 23,940 | +23,940 | $0 | $3,190,244 | +$3,190,244 | 2026-08-14 |
|---|
| Q2 2026 | ARGX
ARGENX SE | | SPONSORED ADR | 0 | 2,811 | +2,811 | $0 | $2,607,961 | +$2,607,961 | 2026-08-14 |
|---|
| Q2 2026 | SHEL
SHELL PLC | | SPON ADS | 0 | 13,049 | +13,049 | $0 | $1,011,819 | +$1,011,819 | 2026-08-14 |
|---|
| Q1 2026 | SNY
SANOFI SA | | SPONSORED ADR | 0 | 2,306,229 | +2,306,229 | $0 | $111,114,113 | +$111,114,113 | 2026-05-15 |
|---|
| Q1 2026 | EQNR
EQUINOR ASA | | SPONSORED ADR | 0 | 439,412 | +439,412 | $0 | $18,543,186 | +$18,543,186 | 2026-05-15 |
|---|
| Q1 2026 | CNTA
CENTESSA PHARMACEUTICALS PLC | | SPONSORED ADS | 0 | 320,430 | +320,430 | $0 | $12,727,480 | +$12,727,480 | 2026-05-15 |
|---|
| Q1 2026 | BNTX
BIONTECH SE | | SPONSORED ADS | 0 | 76,950 | +76,950 | $0 | $6,839,316 | +$6,839,316 | 2026-05-15 |
|---|
| Q1 2026 | CMPS
COMPASS PATHWAYS PLC | | SPONSORED ADS | 0 | 1,000,000 | +1,000,000 | $0 | $5,530,000 | +$5,530,000 | 2026-05-15 |
|---|
| Q1 2026 | AGMB
AGOMAB THERAPEUTICS NV | | SPONSORED ADS | 0 | 75,000 | +75,000 | $0 | $786,750 | +$786,750 | 2026-05-15 |
|---|
| Q1 2026 | NVO
NOVO-NORDISK A S | | ADR | 0 | 9,684 | +9,684 | $0 | $355,887 | +$355,887 | 2026-05-15 |
|---|
| Q1 2026 | LEGN
LEGEND BIOTECH CORP | United States | SPONSORED ADS | 0 | 10,506 | +10,506 | $0 | $190,054 | +$190,054 | 2026-05-15 |
|---|
| Q1 2026 | ADAG
ADAGENE INC | | ADS | 0 | 20,710 | +20,710 | $0 | $81,183 | +$81,183 | 2026-05-15 |
|---|
| Q4 2025 | TSM
TAIWAN SEMICONDUCTOR MFG LTD | | SPONSORED ADS | 0 | 659,462 | +659,462 | $0 | $200,403,907 | +$200,403,907 | 2026-02-13 |
|---|
| Q4 2025 | GSK
GSK PLC | | SPONSORED ADR | 0 | 341,628 | +341,628 | $0 | $16,753,437 | +$16,753,437 | 2026-02-13 |
|---|
| Q4 2025 | GMAB
GENMAB A/S | | SPONSORED ADS | 0 | 506,661 | +506,661 | $0 | $15,605,159 | +$15,605,159 | 2026-02-13 |
|---|
| Q4 2025 | KZIA
KAZIA THERAPEUTICS LTD | | SPONSORED ADS | 0 | 738,321 | +738,321 | $0 | $5,087,032 | +$5,087,032 | 2026-02-13 |
|---|
| Q4 2025 | IVA
INVENTIVA SA | | ADS | 0 | 500,000 | +500,000 | $0 | $2,325,000 | +$2,325,000 | 2026-02-13 |
|---|
| Q4 2025 | GNTA
GENENTA SCIENCE S P A | | SPONSORED ADS | 0 | 219,838 | +219,838 | $0 | $327,559 | +$327,559 | 2026-02-13 |
|---|
| Q3 2025 | NOK
NOKIA CORP | | SPONSORED ADR | 0 | 6,455,099 | +6,455,099 | $0 | $31,049,026 | +$31,049,026 | 2025-11-17 |
|---|
| Q3 2025 | BIDU
BAIDU INC | | SPON ADR REP A | 0 | 187,461 | +187,461 | $0 | $24,701,736 | +$24,701,736 | 2025-11-17 |
|---|
| Q3 2025 | GPCR
STRUCTURE THERAPEUTICS INC | United States | SPONSORED ADS | 0 | 244,848 | +244,848 | $0 | $6,855,744 | +$6,855,744 | 2025-11-17 |
|---|
| Q3 2025 | BNTX
BIONTECH SE | | SPONSORED ADS | 0 | 57,668 | +57,668 | $0 | $5,687,218 | +$5,687,218 | 2025-11-17 |
|---|
| Q3 2025 | SQNS
SEQUANS COMMUNICATIONS S A | | SPONSORED ADS | 0 | 273,770 | +273,770 | $0 | $2,589,864 | +$2,589,864 | 2025-11-17 |
|---|
| Q2 2025 | ARGX
ARGENX SE | | SPONSORED ADR | 0 | 1,836 | +1,836 | $0 | $1,012,040 | +$1,012,040 | 2025-08-14 |
|---|
| Q1 2025 | GSK
GSK PLC | | SPONSORED ADR | 0 | 1,736,358 | +1,736,358 | $0 | $67,266,509 | +$67,266,509 | 2025-05-15 |
|---|
| Q1 2025 | BLTE
BELITE BIO INC | United States | SPONSORED ADS | 0 | 83,623 | +83,623 | $0 | $5,537,515 | +$5,537,515 | 2025-05-15 |
|---|
| Q1 2025 | REEAF
REE AUTOMOTIVE LTD | Israel | SHS CL A NEW | 0 | 1,159,750 | +1,159,750 | $0 | $3,084,935 | +$3,084,935 | 2025-05-15 |
|---|
| Q1 2025 | NVS
NOVARTIS AG | | SPONSORED ADR | 0 | 11,722 | +11,722 | $0 | $1,306,769 | +$1,306,769 | 2025-05-15 |
|---|
| Q4 2024 | NOK
NOKIA CORP | | SPONSORED ADR | 0 | 12,072,395 | +12,072,395 | $0 | $53,480,710 | +$53,480,710 | 2025-02-14 |
|---|
| Q4 2024 | TCOM
TRIP COM GROUP LTD | | ADS | 0 | 175,000 | +175,000 | $0 | $12,015,500 | +$12,015,500 | 2025-02-14 |
|---|
| Q4 2024 | LEGN
LEGEND BIOTECH CORP | United States | SPONSORED ADS | 0 | 250,000 | +250,000 | $0 | $8,135,000 | +$8,135,000 | 2025-02-14 |
|---|
| Q4 2024 | GDS
GDS HLDGS LTD | | SPONSORED ADS | 0 | 129,178 | +129,178 | $0 | $3,069,269 | +$3,069,269 | 2025-02-14 |
|---|
| Q4 2024 | PONY
PONY AI INC | | SPONSORED ADS | 0 | 50,000 | +50,000 | $0 | $717,500 | +$717,500 | 2025-02-14 |
|---|
| Q4 2024 | BNTX
BIONTECH SE | | SPONSORED ADS | 0 | 2,614 | +2,614 | $0 | $297,865 | +$297,865 | 2025-02-14 |
|---|
| Q3 2024 | DAVA
ENDAVA PLC | | ADS | 0 | 1,000,141 | +1,000,141 | $0 | $25,543,601 | +$25,543,601 | 2024-11-14 |
|---|
| Q3 2024 | PDD
PDD HOLDINGS INC | | SPONSORED ADS | 0 | 1,987 | +1,987 | $0 | $267,867 | +$267,867 | 2024-11-14 |
|---|
| Q2 2024 | SNY
SANOFI | | SPONSORED ADR | 0 | 1,418,523 | +1,418,523 | $0 | $68,826,736 | +$68,826,736 | 2024-08-14 |
|---|
| Q2 2024 | NVO
NOVO-NORDISK A S | | ADR | 0 | 256,992 | +256,992 | $0 | $36,683,038 | +$36,683,038 | 2024-08-14 |
|---|
| Q2 2024 | VXRT
VAXART INC | United States | COM NEW | 0 | 1,250,000 | +1,250,000 | $0 | $834,125 | +$834,125 | 2024-08-14 |
|---|
| Q2 2024 | LEGN
LEGEND BIOTECH CORP | United States | SPONSORED ADS | 0 | 10,513 | +10,513 | $0 | $465,621 | +$465,621 | 2024-08-14 |
|---|
| Q2 2024 | NICE
NICE LTD | | SPONSORED ADR | 0 | 1,399 | +1,399 | $0 | $240,586 | +$240,586 | 2024-08-14 |
|---|
| Q1 2024 | SHEL
SHELL PLC | | SPON ADS | 0 | 1,483,061 | +1,483,061 | $0 | $99,424,409 | +$99,424,409 | 2024-05-15 |
|---|
| Q1 2024 | BUD
ANHEUSER BUSCH INBEV SA/NV | | SPONSORED ADR | 0 | 853,699 | +853,699 | $0 | $51,887,825 | +$51,887,825 | 2024-05-15 |
|---|
| Q1 2024 | DAVA
ENDAVA PLC | | ADS | 0 | 912,159 | +912,159 | $0 | $34,698,528 | +$34,698,528 | 2024-05-15 |
|---|
| Q1 2024 | BP
BP PLC | | SPONSORED ADR | 0 | 370,051 | +370,051 | $0 | $13,943,522 | +$13,943,522 | 2024-05-15 |
|---|
| Q1 2024 | ARM
ARM HOLDINGS PLC | | SPONSORED ADR | 0 | 80,201 | +80,201 | $0 | $10,024,323 | +$10,024,323 | 2024-05-15 |
|---|
| Q1 2024 | GSK
GSK PLC | | SPONSORED ADR | 0 | 20,804 | +20,804 | $0 | $891,867 | +$891,867 | 2024-05-15 |
|---|
| Q2 2016 | RIO
RIO TINTO PLC | | SPONSORED ADR | 0 | 177,522 | +177,522 | $0 | $5,556,000 | +$5,556,000 | 2016-08-15 |
|---|
| Q1 2016 | NOK
NOKIA CORP | | SPONSORED ADR | 0 | 2,398,864 | +2,398,864 | $0 | $14,177,000 | +$14,177,000 | 2016-05-16 |
|---|
| Q4 2015 | YRD
YIRENDAI LTD | | SPONSORED ADR | 0 | 175,000 | +175,000 | $0 | $1,654,000 | +$1,654,000 | 2016-02-16 |
|---|
| Q3 2015 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 0 | 24,515 | +24,515 | $0 | $1,384,000 | +$1,384,000 | 2015-11-16 |
|---|
| Q2 2015 | INFY
INFOSYS LTD | | SPONSORED ADR | 0 | 4,001,269 | +4,001,269 | $0 | $63,420,000 | +$63,420,000 | 2015-08-14 |
|---|
| Q2 2015 | ERIC
ERICSSON | | ADR B SEK 10 | 0 | 1,482,359 | +1,482,359 | $0 | $15,476,000 | +$15,476,000 | 2015-08-14 |
|---|
| Q2 2015 | ADAPY
ADAPTIMMUNE THERAPEUTICS PLC | United Kingdom | SPONDS ADR | 0 | 129,853 | +129,853 | $0 | $2,380,000 | +$2,380,000 | 2015-08-14 |
|---|
| Q2 2015 | LKFT
GALAPAGOS NV | | SPON ADR | 0 | 39,320 | +39,320 | $0 | $2,025,000 | +$2,025,000 | 2015-08-14 |
|---|
| Q2 2015 | BZUN
BAOZUN INC | | SPONSORED ADR | 0 | 154,072 | +154,072 | $0 | $1,659,000 | +$1,659,000 | 2015-08-14 |
|---|
| Q1 2015 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 0 | 579,879 | +579,879 | $0 | $36,126,000 | +$36,126,000 | 2015-05-15 |
|---|
| Q1 2015 | NOK
NOKIA CORP | | SPONSORED ADR | 0 | 1,827,607 | +1,827,607 | $0 | $13,853,000 | +$13,853,000 | 2015-05-15 |
|---|
| Q3 2014 | AVAL
GRUPO AVAL ACCIONES Y VALORE | | SPONSORED ADS | 0 | 300,000 | +300,000 | $0 | $4,065,000 | +$4,065,000 | 2014-11-14 |
|---|
| Q2 2014 | BUD
ANHEUSER BUSCH INBEV SA/NV | | SPONSORED ADR | 0 | 84,746 | +84,746 | $0 | $9,741,000 | +$9,741,000 | 2014-08-14 |
|---|
| Q1 2014 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 0 | 375,000 | +375,000 | $0 | $19,815,000 | +$19,815,000 | 2014-05-15 |
|---|
| Q1 2014 | VOD
VODAFONE GROUP PLC NEW | | SPNSR ADR NO PAR | 0 | 252,869 | +252,869 | $0 | $9,308,000 | +$9,308,000 | 2014-05-15 |
|---|
| Q1 2014 | SQM
SOCIEDAD QUIMICA MINERA DE C | | SPON ADR SER B | 0 | 78,669 | +78,669 | $0 | $2,497,000 | +$2,497,000 | 2014-05-15 |
|---|
| Q4 2013 | ATHM
AUTOHOME INC | | SP ADR RP CL A | 0 | 20,000 | +20,000 | $0 | $732,000 | +$732,000 | 2014-02-14 |
|---|
| Q3 2013 | CCU
COMPANIA CERVECERIAS UNIDAS | | SPONSORED ADR | 0 | 175,000 | +175,000 | $0 | $4,657,000 | +$4,657,000 | 2013-11-14 |
|---|
| Q3 2013 | BUD
ANHEUSER BUSCH INBEV SA/NV | | SPONSORED ADR | 0 | 20,635 | +20,635 | $0 | $2,047,000 | +$2,047,000 | 2013-11-14 |
|---|